Patents by Inventor Thomas Joseph Anchordoquy

Thomas Joseph Anchordoquy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230000804
    Abstract: Highly concentrated solutions are disclosed along with methods of inhibiting and/or ameliorating functional neurological disorders of the brain. The method may include administering directly to a brain of a subject a medicament multiple times over a time period of at least two days. The medicament may include a half-life of less than 2 hour in the cerebrospinal fluid. The method may include inhibiting and/or ameliorating a functional neurological disorder of the brain using the medicant.
    Type: Application
    Filed: September 2, 2022
    Publication date: January 5, 2023
    Applicants: Cerebral Therapeutics, Inc., The Regents of the University of Colorado, a body corporate
    Inventors: Daniel J. Abrams, Thomas Joseph Anchordoquy
  • Patent number: 11433038
    Abstract: Highly concentrated solutions are disclosed along with methods of inhibiting and/or ameliorating functional neurological disorders of the brain. The method may include administering directly to a brain of a subject a medicament multiple times over a time period of at least two days. The medicament may include a half-life of less than 2 hour in the cerebrospinal fluid. The method may include inhibiting and/or ameliorating a functional neurological disorder of the brain using the medicant.
    Type: Grant
    Filed: April 16, 2020
    Date of Patent: September 6, 2022
    Assignees: Cerebral Therapeutics, Inc., The Regents of the University of Colorado
    Inventors: Daniel J. Abrams, Thomas Joseph Anchordoquy